Pharmaceutical

Driving Transformation with Trusted Advisory

India’s pharmaceutical sector is a key driver of the country’s economy, renowned globally for its generic drugs, API production, and vaccine manufacturing capabilities. With increasing domestic demand, robust R&D initiatives, and supportive government policies such as the Production-Linked Incentive (PLI) scheme, the sector continues to expand rapidly. India also plays a critical role in global pharmaceutical supply chains, exporting medicines, APIs, and vaccines to over 200 countries.

At Baker Tilly ASA India, we provide comprehensive advisory services to pharmaceutical manufacturers, biotech firms, contract research organizations, and healthcare investors. Whether navigating regulatory compliance, structuring transactions, or optimizing operations, our team delivers solutions that drive growth, efficiency, and global competitiveness.

Our services include:

• Compliance and financial advisory under pharma manufacturing and R&D regulations
• Financial forecasting and modeling supporting growth and investment planning
• Transfer pricing and tax structuring for international pharma networks
• ESG, CSR, and grant audits ensuring transparency and control
• Process optimization and cost management enhancing efficiency
• CERT-In cyber audits protecting IP, data, and clinical systems
• Risk management and internal control reviews ensuring regulatory readiness
• M&A valuation and due diligence for partnerships and acquisitions